|
Anastasia Anastasopoulou
Biostatistician
Munich, Germany
Ahmad Awada, MD. Ph.D.
Institut Jules Bordet
Medical Oncology Unit
Brussels, Belgium
Bettina Ballardini, MD.
Division of Breast Surgery
Fondazione Maugeri, Pavia, Italy
Ross S. Berkowitz, MD. Ph.D.
William H. Baker Professor of Gynecology
Department of Obstetrics and Gynecology
Donald P. Goldstein, MD. Trophoblastic Tumor Registry
Division of Gynecologic Oncology
Brigham and Women's Hospital
Dana Farber Cancer Institute
Co-director of New England Trophoblastic Disease Center
Harvard Medical School, Boston, MA, USA
John Bibb, MD.
Department of Internal Medicine
Division of Hematology Oncology
University of New Mexico Cancer Research and Treatment
Center
Albuquerque, New Mexico, USA
Péter Bõsze, MD. DSc.
Professor of Gynaecology
Chairman of the European Academy of
Gynaecological Cancer (EAGC)
Department of Gynecology
Saint Stephen Hospital
Budapest, Hungary
Fatima Cardoso, MD.
Institut Jules Bordet
Medical Oncology Unit
Brussels, Belgium
Kwai Wa Cheng, Ph.D.
University of Texas,
MD. Anderson Cancer Center
Department of Molecular Therapeutics,
Houston, Texas, USA
Annamaria Ferrero, MD., Ph.D.
University of Torino
Department of Gynecologic Oncology
Mauriziano "Umberto I" Hospital, Torino
Institute for Cancer Research and Treatment,
Candiolo (TO), Italy
Michael L. Friedlander, MD.
Department of Medical Oncology
The Prince of Wales Hospital
and Royal Hospital for Women
Sydney Australia
John P. Geisler, MD.
Indiana Women's Oncology
Division of Gynecologic Oncology
St. Vincent Hospitals and Health Services
Indianapolis, Indiana, USA
Franca Goffredo, PHARM. D.
Pharmacy Service
Institute for Cancer Research and Treatment,
Candiolo (TO), Italy
Donald P. Goldstein, MD. Ph.D.
Professor of Obstetrics and Gynecology
Donald P. Goldstein, MD. Trophoblastic Tumor Registry
Department of Obstetrics and Gynecology
Division of Gynecologic Oncology
Brigham and Women's Hospital
Dana Farber Cancer Institute
New England Trophoblastic Disease Center
Harvard Medical School, Boston, MA, USA
Michelle L Harrison, MD.
Department of Medical Oncology
The Prince of Wales Hospital
Sydney, Australia
Neville F. Hacker, MD.
Department of gynecologic Oncology
Royal Hospital for Women, Sydney, Australia
Gabriel N. Hortobagyi, MD. DhD.
Department of Breast Medical Oncology
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas, USA
Sándor Kerpel-Fronius, MD., DSc.
Professor of Medical Oncology
Department of Pharmacology and Pharmacotherapy
Semmelweis University of Budapest, Hungary
Martine Piccart, MD. Ph.D.
Institut Jules Bordet
Medical Oncology Unit
Brussels, Belgium
Andres Poveda, MD.
Servicio de Oncología Médica
Fundación Instituto Valenciano de Oncología
Valencia, Spain
Lajos Pusztai, MD., DPhil.
Department of Breast Medical Oncology
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas, USA
MaJose Safont, MD.
Servicio de Oncología Médica
Hospital General Univesritario
Valencia, Spain
Stefanie A. Schwartz, Ph.D.
Department of Palliative Care
Boca Raton Community Hospital
Boca Raton, Florida, USA
Davide Serrano, MD.
Division of Chemoprevention
European Institute of Oncology
Milan, Italy
Piero Sismondi, MD., Ph.D.
Professor of Gynecologic Oncology
University of Torino
Chairman of the Department of Gynecologic Oncology
Mauriziano "Umberto I" Hospital, Torino
Institute for Cancer Research and Treatment,
Candiolo (TO) - Italy
|
Alberto Costa, MD.
Director of the European School of Oncology
Division of Breast Surgery
Fondazione Maugeri
Pavia, Italy
Lissandra Dal Lago, MD.
Institut Jules Bordet
Medical Oncology Unit
Brussels, Belgium
Andrea Decensi, MD.
Division of Medical and Preventive Oncology
E.O. Ospedali Galliera
Genoa, Italy
Santiago Dexeus, MD.
Professor of gynecology
Chair of Research in Obstetrics and Gynecology
Department of Obstetrics and Gynecology
Institut Universitari Dexeus
Universitat Autònoma de Barcelona
Barcelona, Spain
Daniela Dompè, MD.
University of Torino
Department of Gynecologic Oncology
Mauriziano "Umberto I" Hospital, Torino
Institute for Cancer Research and Treatment,
Candiolo (TO), Italy
Sándor Eckhardt, MD. DSc.
Professor of Medical Oncology
Professor Emeritus
National Institute of Oncology
Budapest, Hungary
Colleen M. Feltmate, MD.
Instructor in Obstetrics, Gynecology and Reproductive
Biology
Department of Obstetrics and Gynecology
Donald P. Goldstein, MD. Trophoblastic Tumor Registry
Division of Gynecologic Oncology
Brigham and Women's Hospital
Dana Farber Cancer Institute
New England Trophoblastic Disease Center
Harvard Medical School
Boston, MA, USA
John P. Lahad
University of Texas,
MD. Anderson Cancer Center
Department of Molecular Therapeutics,
Houston, Texas, USA
Georgiann C. Linnemeier, MD.
Indiana Women's Oncology
Division of Gynecologic Oncology
St. Vincent Hospitals and Health Services
Indianapolis, Indiana USA
Kelly J. Manahan, MD.
Indiana Women's Oncology
Division of Gynecologic Oncology
St. Vincent Hospitals and Health Services
Indianapolis, Indiana USA
Max Mano, MD.
Institut Jules Bordet
Medical Oncology Unit
Brussels, Belgium
Rosella Marchese (head nurse)
Nursing Service
Institute for Cancer Research and Treatment,
Candiolo (TO), Italy
Maurie Markman, MD.
Vice President for Clinical Research
University of Texas
MD. Anderson Cancer Center
Houston, Texas, USA
Francesco Marocco, MD.
University of Torino
Department of Gynecologic Oncology
Mauriziano "Umberto I" Hospital, Torino
Institute for Cancer Research and Treatment,
Candiolo (TO), Italy
Gavin M. Marx, MD.
Department of Medical Oncology
The Hornsby Hospital
Sydney, Australia
Gordon B. Mills, MD., Ph.D.
University of Texas,
MD. Anderson Cancer Center
Department of Molecular Therapeutics,
Houston, Texas, USA
János L. Tanyi, MD.
Department of Molecular Therapeutics,
The University of Texas
MD. Anderson Cancer Center
Houston, Texas, USA
Ignacio Tusquets, MD.
Professor of Medical Oncology
Service of Medical Oncology
Institut Universitari Dexeus
Universitat Autònoma de Barcelona, Barcelona, Spain.
Jan Van den Brande, MD.
Department of Medical Oncology
University Hospital Antwerp
Edegem, Belgium
Jan B. Vermorken, MD., Ph.D.
Professor of Medical Oncology
University of Antwerp
Head of Department of Oncology
University Hospital Antwerp
Edegem, Belgium
Claire Verschraegen, MD.
Cancer Research and Treatment Center
University of New Mexico
Albuquerque, New Mexico, USA
Michael C. Wiemann, MD.
Indiana Women's Oncology
Division of Gynecologic Oncology
St. Vincent Hospitals and Health Services
Indianapolis, Indiana USA
Katherine M. Zahasky, RN.CNP.
Department of Medical Oncology
Mayo Clinic
Rochester, Minnesota, USA
|